{"url_path":"/sec/pdsb/8-k/2026-05-13/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1472091/0001140361-26-020934-index.html","accession_number":"0001140361-26-020934","cik":"0001472091","ticker":"PDSB","issuer_name":"PDS Biotechnology Corp","edgar_url":"https://www.sec.gov/Archives/edgar/data/1472091/0001140361-26-020934-index.html","primary_entity_key":"0001472091","primary_entity_name":"PDS Biotechnology Corp"},"word_count":83,"has_tables":true,"body_markdown":"Item 9.01\n\nFinancial Statements and Exhibits.\n\n(d)\n\nExhibits.\n\nExhibit\n\nNumber\n\nDescription\n\n[99.1](ef20073195_ex99-1.htm)\n\nPress Release dated May 13, 2026.\n\n104\n\nCover Page Interactive Data File (embedded within the Inline XBRL document).\n\nSignature\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its\nbehalf by the undersigned hereunto duly authorized.\n\n \n\n \n\nPDS BIOTECHNOLOGY CORPORATION\n\n \n\n \n\n \n\nDate: May 13, 2026\n\nBy: /s/ Frank Bedu-Addo, Ph.D.\n\n \n\n \n\nName: Frank Bedu-Addo, Ph.D.\n\n \n\n \n\nTitle: President and Chief Executive Officer"}